Track the Bluejay Diagnostics, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Bluejay Diagnostics, Inc. has logged 23 reports. Market capitalisation: €1.1m. The latest transaction was disclosed on 18 August 2026 (Attribution). Among the most active insiders: Dey Indranil. All data is free.
23
Insider Decl.
n/a
Thresholds
€258,883
12 ops.
Buy Volume
€42,726
1 ops.
Sell Volume
42Σ signal
Buys €258,883€42,726 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,500 shares@ US$0.9577.6% of flowCommon StockSEC:0001213900-22-013084:0
Canonical exit: 12 Jun 2022 (T+90)
23 of 23 declarations
Acerca de Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. es una empresa centrada en el desarrollo de soluciones de diagnóstico médico. Su objetivo es mejorar la atención médica a través de tecnologías innovadoras.